- Home
- BCAB vs MRM Comparison
BCAB vs MRM Comparison
Compare BCAB & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | MRM |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.7M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BCAB | MRM |
|---|---|---|
| Price | $4.47 | $1.09 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 810.3K | 18.3K |
| Earning Date | 05-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.60 |
| 52 Week High | $6.52 | $4.45 |
Technical Indicators
Market Signals| Indicator | BCAB | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 78.12 | 31.55 |
| Support Level | $0.36 | $1.04 |
| Resistance Level | $6.52 | $1.64 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | 0.45 | 0.01 |
| Stochastic Oscillator | 66.88 | 22.38 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.